Serum carbohydrate antigen 19-9 (CA199) levels are often elevated in ICC patients, rather than elevated serum alpha-fetoprotein (AFP) levels like those in HCC patients. This evidence concerns the gene AFP and intrahepatic cholangiocarcinoma.